Live feed
Filing
SC 13G
SC 13G0001535610-18-000080·Phio Pharmaceuticals Corp.
Schedule 13G ownership disclosure
RXI PHARMACEUTICALS
Security class unavailable · CUSIP: 74979C808
Event date: 2018-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 377,652
- Percent of class
- 8.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000080
- Form type
- SC 13G
- Filer
- Phio Pharmaceuticals Corp.
- CIK
- CIK 1533040
- Filed
- Apr 11, 2018
- Reporting period
- Apr 09, 2018
- Description
- Schedule 13G beneficial ownership